{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:54:37Z","timestamp":1792580077728,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004491","name":"Balikesir University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000544","name":"British Association for Psychopharmacology","doi-asserted-by":"publisher","award":["2022\/065"],"award-info":[{"award-number":["2022\/065"]}],"id":[{"id":"10.13039\/501100000544","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.lfs.2026.124245","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T07:35:12Z","timestamp":1769672112000},"page":"124245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Dose-dependent effects of vildagliptin (DPP-4 inhibitor) in a scopolamine-induced memory impairment model in rats"],"prefix":"10.1016","volume":"389","author":[{"given":"Fazilet","family":"\u015een Metin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Aks\u00f6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2026.124245_bb0005","series-title":"Dementia in Refugees and Migrants: Epidemiology, Public Health Implications and Global Responses","author":"Ancidoni","year":"2025"},{"key":"10.1016\/j.lfs.2026.124245_bb0010","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer\u2019s disease facts and figures","volume":"20","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.lfs.2026.124245_bb0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4239\/wjd.v13.i4.319","article-title":"Cognitive disorder and dementia in type 2 diabetes mellitus","volume":"13","author":"Ortiz","year":"2022","journal-title":"World J. Diabetes"},{"issue":"10","key":"10.1016\/j.lfs.2026.124245_bb0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","article-title":"Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications","volume":"14","author":"Biessels","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.lfs.2026.124245_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102383","article-title":"True or false? Alzheimer\u2019s disease is type 3 diabetes: evidences from bench to bedside","volume":"99","author":"Peng","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.lfs.2026.124245_bb0030","article-title":"Risk of dementia in older patients with type 2 diabetes on dipeptidyl-peptidase IV inhibitors versus sulfonylureas: a real-world population-based cohort study","volume":"8","author":"Kim","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.lfs.2026.124245_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2019.06.001","article-title":"Effects of vildagliptin, a DPP-4 inhibitor, in elderly diabetic patients with mild cognitive impairment","volume":"84","author":"Borz\u00ec","year":"2019","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.lfs.2026.124245_bb0040","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","article-title":"The cholinergic system in aging and neuronal degeneration","volume":"221","author":"Schliebs","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.lfs.2026.124245_bb0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bcp.2013.06.016","article-title":"Animal models of CNS disorders","volume":"87","author":"McGonigle","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2026.124245_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01489","article-title":"The cholinergic system modulates memory and hippocampal plasticity via its interactions with non-neuronal cells","volume":"8","author":"Maurer","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2026.124245_bb0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejphar.2015.11.033","article-title":"Favorable effects of vildagliptin on metabolic and cognitive dysfunctions in streptozotocin-induced diabetic rats","volume":"769","author":"El Batsh","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2026.124245_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104508","article-title":"Mechanistic study of gold nanoparticles of vildagliptin and vitamin E in diabetic cognitive impairment","volume":"84","author":"Pradhan","year":"2023","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.lfs.2026.124245_bb0065","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/jphp.12148","article-title":"Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer\u2019s disease","volume":"65","author":"Kosaraju","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.lfs.2026.124245_bb0070","article-title":"Role of cholinergic signaling in Alzheimer\u2019s disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2026.124245_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation","volume":"20","author":"Chen","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.lfs.2026.124245_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106531","article-title":"Malondialdehyde in cognitive impairment: a systematic review and meta-analysis","volume":"181","author":"Zoroddu","year":"2026","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.lfs.2026.124245_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124521","article-title":"Using the Morris water maze to assess spatial learning and memory in weanling mice","volume":"10","author":"Barnhart","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2026.124245_bb0090","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.lfs.2026.124245_bb0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1742-1241.2007.01685.x","article-title":"The islet enhancer vildagliptin: mechanisms of improved glucose metabolism","volume":"62","author":"Ahr\u00e9n","year":"2008","journal-title":"Int. J. Clin. Pract. Suppl."},{"key":"10.1016\/j.lfs.2026.124245_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104615","article-title":"Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure","volume":"152","author":"Yoon","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2026.124245_bb0105","article-title":"Neuroprotective mechanisms of glucagon-like peptide-1-based therapies in ischemic stroke: an update based on preclinical research","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.lfs.2026.124245_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JOE-12-0521","article-title":"DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats","volume":"218","author":"Pintana","year":"2013","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.lfs.2026.124245_bb0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.taap.2017.08.005","article-title":"SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats","volume":"333","author":"Sa-nguanmoo","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.lfs.2026.124245_bb0120","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/ejn.12088","article-title":"DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption","volume":"37","author":"Pipatpiboon","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.lfs.2026.124245_bb0125","first-page":"4113","article-title":"Vildagliptin prevents cognitive deficits and neuronal apoptosis in a rat model of Alzheimer\u2019s disease","volume":"17","author":"Ma","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2026.124245_bb0130","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.13005\/bpj\/2462","article-title":"Effect of vildagliptin on cognitive deficits in an experimental model of Alzheimer\u2019s disease","volume":"15","author":"Dash","year":"2022","journal-title":"Biomed. Pharmacol. J."},{"key":"10.1016\/j.lfs.2026.124245_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173612","article-title":"Neuroprotective effects of vildagliptin on drug induced Alzheimer\u2019s disease in rats with metabolic syndrome: role of hippocampal klotho and AKT signaling pathways","volume":"889","author":"Yossef","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2026.124245_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/app14062582","article-title":"Changes in paraoxonase, \u03b2-glucosidase, and carbonic anhydrase enzymes related to age and scopolamine-induced memory impairment in rats","volume":"14","author":"Yildirim","year":"2024","journal-title":"Appl. Sci."},{"key":"10.1016\/j.lfs.2026.124245_bb0145","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.pharep.2019.04.015","article-title":"The protective effect of metformin in scopolamine-induced learning and memory impairment in rats","volume":"71","author":"Aksoz","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.lfs.2026.124245_bb0150","first-page":"5100","article-title":"Vildagliptin, a DPP4 inhibitor, alleviates diabetes-associated cognitive deficits by decreasing the levels of apoptosis-related proteins in the rat Hippocampus","volume":"15","author":"Zhang","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.lfs.2026.124245_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114238","article-title":"Vildagliptin restores cognitive function and mitigates hippocampal neuronal apoptosis in cisplatin-induced chemo-brain: imperative roles of AMPK\/Akt\/CREB\/BDNF signaling cascades","volume":"159","author":"Mahmoud","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2026.124245_bb0160","first-page":"15","article-title":"Naringenin protects against scopolamine-induced dementia in rats","volume":"52","author":"Zaki","year":"2014","journal-title":"Bull. Fac. Pharm. Cairo Univ."},{"key":"10.1016\/j.lfs.2026.124245_bb0165","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00210-019-01616-3","article-title":"Combined vildagliptin and memantine treatment downregulates expression of amyloid precursor protein, and total and phosphorylated tau in a rat model of combined Alzheimer\u2019s disease and type 2 diabetes","volume":"392","author":"Khalaf","year":"2019","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.lfs.2026.124245_bb0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12640-009-9000-x","article-title":"Consumption of grape seed extract prevents amyloid-\u03b2 deposition and attenuates inflammation in brain of an Alzheimer\u2019s disease mouse","volume":"15","author":"Wang","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.lfs.2026.124245_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110783","article-title":"Levistilide a ameliorates neuroinflammation via inhibiting JAK2\/STAT3 signaling for neuroprotection and cognitive improvement in scopolamine-induced Alzheimer\u2019s disease mouse model","volume":"124","author":"Ni","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2026.124245_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.sjbs.2023.103560","article-title":"Sterubin protects against chemically-induced Alzheimer\u2019s disease by reducing biomarkers of inflammation- IL-6\/IL-\u03b2\/TNF-\u03b1 and oxidative stress- SOD\/MDA in rats","volume":"30","author":"Kazmi","year":"2023","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.lfs.2026.124245_bb0185","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s11011-022-01086-2","article-title":"Vitamin D3 supplementation ameliorates cognitive impairment and alters neurodegenerative and inflammatory markers in scopolamine induced rat model","volume":"37","author":"Patel","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.lfs.2026.124245_bb0190","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.fct.2013.12.025","article-title":"Total isoflavones from soybean and tempeh reversed scopolamine-induced amnesia, improved cholinergic activities and reduced neuroinflammation in brain","volume":"65","author":"Ahmad","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.lfs.2026.124245_bb0195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbr.2014.03.026","article-title":"Dipeptidyl peptidase-4 inhibition by Pterocarpus marsupium and Eugenia jambolana ameliorates streptozotocin induced Alzheimer\u2019s disease","volume":"267","author":"Kosaraju","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.lfs.2026.124245_bb0200","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s11011-017-0059-4","article-title":"Beneficial effects of liraglutide (GLP1 analog) in the hippocampal inflammation","volume":"32","author":"Barreto-Vianna","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.lfs.2026.124245_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107503","article-title":"Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions","volume":"209","author":"Shao","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2026.124245_bb0210","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ni.2237","article-title":"Regulation of inflammasome signaling","volume":"13","author":"Rathinam","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2026.124245_bb0215","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/861231","article-title":"Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity","volume":"2014","author":"Olmos","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.lfs.2026.124245_bb0220","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/brbi.1995.1033","article-title":"Interleukin-1 and tumor necrosis factor-\u03b1 synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors","volume":"9","author":"Chao","year":"1995","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.lfs.2026.124245_bb0225","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1471-4159.2006.03907.x","article-title":"Oxidative stress and neurodegeneration: where are we now?","volume":"97","author":"Halliwell","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2026.124245_bb0230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/01480545.2018.1463238","article-title":"Beneficial effects of Urtica dioica on scopolamine-induced memory impairment in rats: protection against acetylcholinesterase activity and neuronal oxidative damage","volume":"42","author":"Ghasemi","year":"2019","journal-title":"Drug Chem. Toxicol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:20:49Z","timestamp":1770830449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320526000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":46,"alternative-id":["S0024320526000536"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124245","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-dependent effects of vildagliptin (DPP-4 inhibitor) in a scopolamine-induced memory impairment model in rats","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124245"}}